PR Peptides Research

Synthetic Peptide Compounds · Checked

GHK-Cu Spray

Every price, divided down to the milligram.

Sticker prices hide what a compound actually costs, because vial sizes differ. So we divide the listing by its stated peptide content and show the real cost per milligram.

GHK-Cu Spray product vial
Tracked price — per milligram

Vendors pay us a commission when you buy through our links. It never changes the order — rows are sorted by measured price per mg, and every flag is computed from the data shown. Read the full disclosure

Where to buy

One listing tracked

How this page is funded: vendors listed here pay us a commission when you buy through our links. Commissions never change the ranking — rows are ordered by measured price per mg, and flags are computed from the data on this page. Sponsored placements, if any, are always labeled.

On this page
Before you compare

How to read these rows

Verify the COA

A certificate of analysis should come from an independent lab, reference the exact batch number on the label, and be recent. Vendor-issued documents without a named third-party lab carry less weight — the COA row links to what each vendor publishes.

Match the format

Lyophilized vials and sprays are different products with different concentrations. That is why sprays sit outside the $/mg ranking — compare vials to vials, sprays to sprays.

Count the total cost

Shipping fees, free-shipping thresholds and active discount codes can flip which vendor is actually cheapest for your order size. The $/mg figure is the baseline; the shipping and code details finish the math.

Methodology

How we rank

The row below carries a price per mg figure: listed price divided by stated peptide content, excluding shipping and codes. It is the same calculation applied on every compound page, so a figure here is directly comparable to one anywhere else on the site.

We currently track a single listing for this compound. When a second vendor is added the rows are ordered by measured $/mg, and the flags for testing and shipping are computed from the data shown. Each row carries its own verification date.

Synthetic Peptide Compounds

Copper-tripeptide skin & tissue-remodelling molecule

Copper peptide GHK-Cu — the gold standard for collagen synthesis, skin regeneration, and senescence research.

A copper-chelating 3-residue peptide (Gly-His-Lys) that binds Cu²⁺ with high affinity. Characterised in the primary literature as a modulator of DNA gene-expression signatures related to tissue remodelling and copper transport. For laboratory characterisation only.

GHK-Cu — clinical & mechanistic profile

GHK-Cu is a naturally occurring copper-binding tripeptide that regulates over 4,000 genes involved in peptide research, collagen synthesis, and anti-inflammatory responses. 2025-2026 research confirms it delivers bioavailable copper, resets cellular gene expression to a younger-marker state, reduces IL-6/TNF-alpha, supports DNA repair via 84 anti-cancer-related genes, and shows cumulative collagen remodeling with 3-6 months of use.

Studied applications

Gene expression modulation
studied for effects on over 4,000 genes affecting regeneration and inflammation
Wound healing
investigated in dermal repair, with topical applications better characterized than systemic
Skin aging
researched for collagen/elastin synthesis and antioxidant effects
Tissue remodeling
examined for extracellular matrix restructuring and metalloproteinase modulation
Anti-inflammatory
studied for effects on inflammatory cytokine expression

Research constraints & safety notes

Topical applications far better studied than systemic/injectable use
Human data primarily observational or from cosmetic studies rather than controlled clinical trials
Not approved as a drug by FDA or other regulatory agencies
Effects require copper availability—chelators abolish activity
Skin penetration requires specific pH and formulation considerations

GHK-Cu is a naturally occurring copper-binding tripeptide that regulates over 4,000 genes involved in peptide research, collagen synthesis, and anti-inflammatory responses. 2025-2026 research confirms it delivers bioavailable copper, resets cellular gene expression to a younger-marker state, reduces IL-6/TNF-alpha, supports DNA repair via 84 anti-cancer-related genes, and shows cumulative collagen remodeling with 3-6 months of use. It has a molecular formula C14H24N6O4Cu (copper complex), mass 340.38 Da (free peptide) / 401.93 Da (copper complex) Da. Its published amino-acid sequence is Gly-His-Lys. Common synonyms in the literature include Copper Peptide GHK, GHK Copper, and Glycyl-L-histidyl-L-lysine copper.

What it’s studied for

Investigation of GHK-Cu to date is clinical-investigational, with the majority of citations concentrated in animal models and in-vitro assays rather than randomized controlled human trials. Published work referencing GHK-Cu spans Topical wound healing: Extensive research has examined GHK-Cu in dermal wound models, showing effects on reepithelialization, collagen deposition, and wound closure. GHK-Cu superiority over GHK alone has been demonstrated in murine wounds, with effects requiring Cu²⁺ (abolished by chelators like bathocuproine), Skin aging and cosmetic research: Studies have investigated GHK-Cu for effects on photoaging, dermal collagen research, skin thickness, and elasticity. Most human data comes from cosmetic product studies rather than rigorous clinical trials, and Gene expression studies: Microarray analyses have shown GHK-Cu modulates expression of over 4,000 genes, with structural genes upregulated and inflammatory/damaging genes downregulated. Key affected pathways include TGF-β signaling, DNA repair, and antioxidant systems. Proposed mechanisms in the literature include Copper delivery: forms stable complex with Cu²⁺ (binding constant log10 ≈ 16.44), delivering copper while silencing redox toxicity and Gene expression: upregulates structural genes (TGF-β pathway) and downregulates inflammatory genes (IL-6, fibrinogen). None of this material describes therapeutic outcomes in humans, and No vendor listed here provides dosing guidance for GHK-Cu outside laboratory research.

Related research

For the full mechanistic profile, published references, and constraint notes on GHK-Cu, see the GHK-Cu research page. All references cited on that page are peer-reviewed primary literature.

For research use only. This summary is a research-scientific overview compiled from peer-reviewed sources. It is not medical advice and is not intended for human or veterinary consumption.

Mechanism of action

Receptor engagement in the primary literature

Binding and functional-assay data for GHK-Cu, from peer-reviewed in-vitro pharmacology publications. Values are receptor activity parameters — not clinical outcomes.

Cu²⁺
Copper(II) bindingHigh-affinity chelator (in vitro)

GHK-Cu forms a 1:1 copper complex with picomolar affinity, described in the literature as the essential feature underlying subsequent biological activities.

Source: Pickart et al., Biomed Res Int 2015

MMP
Matrix metalloproteinasesModulator (in vitro)

Dermal fibroblast in-vitro cultures report GHK-Cu-mediated modulation of MMP-1, MMP-2, and TIMP-1/2 expression, implicated in extracellular-matrix remodelling.

Source: Pickart et al., Int J Mol Sci 2018

NRF2
NRF2 antioxidant pathwayActivator (in vitro)

Transcriptomic studies of GHK-Cu-treated fibroblasts describe activation of the NRF2 antioxidant-response pathway.

Source: Pickart et al., Cosmetics 2018

In-vitro / preclinical characterisation only — no clinical or therapeutic claim is expressed or implied. Research use only.

Study framework

Investigational context

Study designs referencing this compound in the published literature. Descriptions cover framework only — phase, participant count, duration, and citation — not outcomes. Click a card to review the source directly.

Reference chemistry

Specifications

GHK-Cu specifications
AttributeValue
Molecular FormulaC14H23CuN6O4
CAS Number89030-95-5
Molecular Weight403.92 g/mol
SequenceGly-His-Lys:Cu
Sequence length3 residues
PubChem CID74763 ↗
Cited sources

Peer-reviewed literature

[1]
Pickart L, Margolina A
GHK-Cu structural and protective actions review (2018) — PMID: 29986520
View source ↗
[2]
Pickart L, et al.
GHK-Cu gene expression effects — PMID: 25815989
View source ↗
[3]
Wound healing and tissue remodeling mechanisms
PMID: 22585374
View source ↗
[4]
GHK-Cu in skin aging and wound repair (2022)
PMID: 35083444
View source ↗
[5]
Copper peptides and skin regeneration
PMID: 22666519
View source ↗
Price per mg View